Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2655

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 2655
---
ly
    Owned

    Percent
    of
    Class

    Officers and Directors

    Geoffrey
    Dow
     
    President, Chief
    Executive Officer and Director

    16,766
    (2)

    1.14
    %
  
    Tyrone
    Miller
     
    Chief Financial Officer

    6,074
    (3)

    *

    Kristen
    Landon
     
    Chief Commercial Officer

    5,374
    (4)

    *

    Charles
    Allen
     
    Director

    518
    (5)

    *

    Cheryl
    Xu
     
    Director

    4,100
    (6)

    *

    Stephen
    Toovey
     
    Director

    518
    (7)

    *

    Paul
    Field
     
    Director

    518
    (8)

    *

    Officers
    and Directors as a Group (total of 7 persons)

    33,868

    2.30
    %

*Less
than 1%

    (1)
    Percentages based on 1,472,891 shares of common stock issued and outstanding
as of March 27, 2025 plus shares of common stock the person has the right to acquire within 60 days thereafter. Unless otherwise indicated,
the principal address of the named executives and directors is c/o 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036. On February
24, 2025, the Company effectuated a 1-for-5 Reverse Stock Split of its outstanding common stock. Accordingly, all share numbers presented
in this table have been adjusted to reflect the Reverse Stock Split.

    (2)
    Includes
    (i) 4,471 shares of our common stock held in the name of Geoffrey Dow, (ii) 11,120 shares of common stock held by the Geoffrey S.
    Dow Revocable Trust (the “Dow Trust”), of which Geoffrey Dow is the trustee and has control over the voting and disposition
    of the shares of common stock held by the Dow Trust, (iii) 175 shares of common stock issuable upon exercise of warrants issued to
    the Geoffrey S. Dow Revocable Trust and (iv) 1,000 shares underlying fully vested options exercisable into common stock at a per
    share exercise price of $60